Am J Transplant, Volume 18, Suppl 3 Archives - Page 180 of 211 - ATC Abstracts

2018 American Transplant Congress
Sirolimus Use Improves Cancer-Free Survival Following Transplantation: A Single Center 10-Year Analysis
P. Chen,² L. Nair,² A. Ata,² D. Conti,¹ R. Lopez-Soler.¹
¹Surgery, Section of Transplantation, Albany Medical College, Albany, NY; ²Surgery, Albany Medical College, Albany, NY.
Introduction:In previous published results, we showed that the use of Sirolimus-based immunosuppression regimens had equivalent patient and graft 10-year survival compared to historical controls maintained…
2018 American Transplant Congress
Cognition after Belatacept Conversion
C. Ogbejesi, E. Cohen, K. Belfield, W. Asch.
Yale University, New Haven, CT.
Intro: Kidney Transplant Recipients (KTRs) taking calcineurin inhibitors (CNIs) can experience varying drug toxicities. Less well studied compared to the metabolic consequences, many patients report…
2018 American Transplant Congress
Outcomes of Early Steroid Withdrawal in 6-Antigen Human Leukocyte Antigen (HLA)-Matched Kidney Transplant Recipients
H. Champion, K. Holdener, B. Astor, F. Aziz, D. Mandelbrot.
UW Health, Madison, WI.
Background: Steroids are often used as part of standard immunosuppressant therapy to help prevent acute rejection in renal transplant patients. However, the long term adverse…
2018 American Transplant Congress
Estimated GFR for Living Kidney Donor Evaluation before and after Donor Nephrectomy
Y. Kakuta,¹ M. Okumi,¹ R. Imamura,² N. Ichimaru,² S. Takahara,² H. Ishida,¹ K. Tanabe.¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan; ²Urology, Osaka Graduate School of Medicine, Suita, Osaka, Japan.
BackgroundKidney transplantation from living donors is an important treatment for patients with kidney failure. An accurate evaluation of renal function must be conducted before and…
2018 American Transplant Congress
Shortening Length of Post-Operative In-Patient Stay for Living Kidney Donors
M. Loiselle, H. Bruschwein, J. Jacobs, S. Gulin, T. Rose, H. Arora, R. Nash, A. Toledo, T. Kozlowski.
Department of Surgery, University of North Carolina, Chapel Hill.
Purpose. The study analyzes the impact of psychiatric history on postoperative length of hospital stay (LOS) of living kidney donors (LD) and initial assessment of…
2018 American Transplant Congress
Pinching an Inch in Kidney Transplantation: Subcutaneous Depth as a Risk Factor for Wound Complications
R. Ruiz, T. Cox, K. Wicklund, N. Jennings, N. Onaca, G. Testa, T. Anthony, H. Fernandez, J. Bayer, G. McKenna.
Baylor All Saints Medical Center, Fort Worth.
Wound complications after kidney transplant (KTx) consume valuable resources, including prolonged hospital stays and increased costs. Known risk factors include immunosuppression exposure, diabetes, and obesity…
2018 American Transplant Congress
Krüppel-Like Factor 15 is a Key Suppressor of the Glomerular Epithelial Cell Fibrosis under Centrifugal Force Driven Pressure
M. Yu,¹ Y. Kim,¹ H. Lee,¹ J. Lee,² R. Cha,³ C. Lee,⁴ Y. Kim,¹ S. Yang.⁵
¹Seoul National University Hospital, Seoul, Korea; ²Seoul National University Boramae Medical Center, Seoul, Korea; ³National Medical Center, Seoul, Korea; ⁴Cheju Halla General Hospital, Jeju, Korea; ⁵Seoul National University Kidney Research Institue, Seoul, Korea.
Hypertension is known to be responsible for a reduction in the number of functional nephrons of glomeruli due to fibrosis, which develops into a chronic…
2018 American Transplant Congress
Prediction of BK Viremia by Urine BK Viral Load in Renal Transplant Patients: BK Viral Load Results in Paired Urine and Plasma Samples
K. Madden,¹ C. Janitell,² S. Yang.²
¹Pathology, University of New Mexico, Albuquerque, NM; ²Microbiology, Tricore Reference Laboratories, Albuquerque, NM.
BK virus (BKV) associated nephropathy (BKVAN) affects up to 10% of renal transplant recipients, causing graft failure without intervention; a presumptive BKVAN diagnosis is made…
2018 American Transplant Congress
Rituximab Induction to Prevent the Recurrence of PSC after Liver Transplantation-The Lessons Learned from ABO-Incompatible Living Donor Liver Transplantation-
Y. Yamada,¹ K. Hoshino,¹ M. Shinoda,¹ H. Obara,¹ S. Uemoto,³ T. Kaido,³ H. Okajima,³ T. Yagi,⁴ T. Yoshizumi,⁵ Y. Inomata,⁶ T. Hibi,⁶ K. Kubota,⁷ T. Suzuki,⁸ Y. Kitagawa,¹ H. Egawa,² T. Kuroda.¹
¹Surgery, Keio University School of Medicine, Tokyo, Japan; ²Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan; ³Division of Hepato-Biliary-Pancreatic Surgery and Transplant Surgery, Kyoto University, Kyoto, Japan; ⁴Hepato-Biliary and Pancreatic Surgery, Okayama University, Okayama, Japan; ⁵Department of Surgery, Kyushu University, Fukuoka, Japan; ⁶Transplantation and Pediatric Surgery, Kumamoto University, Kumamoto, Japan; ⁷Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan; ⁸Department of Pediatric Surgery, Fujita Health University School of Medicine, Aichi, Japan.
Background: Multiple studies have failed to reveal an effective method for preventing the recurrence of primary sclerosing cholangitis (PSC) after liver transplantation (LTx). A national…
2018 American Transplant Congress
Factors Associated with Listing for Liver Transplantation in an OPO Other Than the Resident OPO
S. Zhou, A. Massie, S. Gentry, D. Segev.
The JHU, Baltimore.
Geographic disparity in access to liver transplantation has been well described. Candidates may travel to be listed in OPOs with better access. We hypothesized that…